A Pro-Endocrine Pancreatic Islet Transcriptional Program Established During Development Is Retained in Human Gallbladder Epithelial Cells.

Autor: Joglekar MV; Diabetes and Islet Biology Group, School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia., Sahu S; Diabetes and Islet Biology Group, School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia., Wong WKM; Diabetes and Islet Biology Group, School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia., Satoor SN; Diabetes and Islet Biology Group, School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia., Dong CX; Diabetes and Islet Biology Group, School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia., Farr RJ; Diabetes and Islet Biology Group, School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia., Williams MD; Diabetes and Islet Biology Group, School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia., Pandya P; Diabetes and Islet Biology Group, School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia., Jhala G; Immunology and Diabetes Group, St. Vincent's Institute for Medical Research, Victoria, Australia., Yang SNY; Diabetes and Islet Biology Group, School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia., Chew YV; The Westmead Institute for Medical Research, Westmead Millenium Institute, University of Sydney, Westmead, New South Wales, Australia., Hetherington N; Diabetes and Islet Biology Group, School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia., Thiruchevlam D; Department of Gastroenterology, St. Vincent's Hospital, Melbourne, Victoria, Australia., Mitnala S; Surgical Gastroenterology Research, Asian Institute of Gastroenterology, Hyderabad, India., Rao GV; Surgical Gastroenterology Research, Asian Institute of Gastroenterology, Hyderabad, India., Reddy DN; Surgical Gastroenterology Research, Asian Institute of Gastroenterology, Hyderabad, India., Loudovaris T; Immunology and Diabetes Group, St. Vincent's Institute for Medical Research, Victoria, Australia., Hawthorne WJ; The Westmead Institute for Medical Research, Westmead Millenium Institute, University of Sydney, Westmead, New South Wales, Australia., Elefanty AG; Murdoch Childrens Research Institute, Parkville, Victoria, Australia., Joglekar VM; Shree Seva Medical Foundation, Shirwal, India., Stanley EG; Murdoch Childrens Research Institute, Parkville, Victoria, Australia., Martin D; Upper Gastrointestinal Surgery, Strathfield Hospital, Strathfield, New South Wales, Australia., Thomas HE; Immunology and Diabetes Group, St. Vincent's Institute for Medical Research, Victoria, Australia., Tosh D; Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom., Dalgaard LT; Section of Eukaryotic Cell Biology, Department of Science and Environment, Roskilde University, Roskilde, Denmark., Hardikar AA; Diabetes and Islet Biology Group, School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia. Electronic address: a.hardikar@westernsydney.edu.au.

Publikováno v: Cellular and molecular gastroenterology and hepatology [Cell Mol Gastroenterol Hepatol] 2022; Vol. 13 (5), pp. 1530-1553.e4. Date of Electronic Publication: 2022 Jan 12.

RK-33 Is a Broad-Spectrum Antiviral Agent That Targets DEAD-Box RNA Helicase DDX3X.

Autor: Yang SNY; Nuclear Signaling Laboratory, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia., Atkinson SC; Infection & Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia., Audsley MD; Infection & Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia., Heaton SM; Infection & Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia., Jans DA; Nuclear Signaling Laboratory, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia., Borg NA; Infection & Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia.

Publikováno v: Cells [Cells] 2020 Jan 09; Vol. 9 (1). Date of Electronic Publication: 2020 Jan 09.

Novel Flavivirus Antiviral That Targets the Host Nuclear Transport Importin α/β1 Heterodimer.

Autor: Yang SNY; Nuclear Signaling Laboratory, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Vic. 3800, Australia. sundy.yang@monash.edu., Atkinson SC; Infection & Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Vic. 3800, Australia. sarah.atkinson@monash.edu., Fraser JE; Nuclear Signaling Laboratory, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Vic. 3800, Australia. johanna.fraser@eliminatedengue.com., Wang C; Nuclear Signaling Laboratory, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Vic. 3800, Australia. chunxiao.wang@monash.edu., Maher B; Nuclear Signaling Laboratory, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Vic. 3800, Australia. belinda.maher@monash.edu., Roman N; School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW 2650, Australia. nroman@csu.edu.au., Forwood JK; School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW 2650, Australia. jforwood@csu.edu.au., Wagstaff KM; Nuclear Signaling Laboratory, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Vic. 3800, Australia. kylie.wagstaff@monash.edu., Borg NA; Infection & Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Vic. 3800, Australia. natalie.borg@monash.edu., Jans DA; Nuclear Signaling Laboratory, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Vic. 3800, Australia. David.Jans@monash.edu.

Publikováno v: Cells [Cells] 2019 Mar 24; Vol. 8 (3). Date of Electronic Publication: 2019 Mar 24.

Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by protease-activated receptor-1 transactivation of the transforming growth factor beta type I receptor.

Autor: Burch ML; Diabetes and Cell Biology Laboratory, BakerIDI Heart and Diabetes Institute, Melbourne, 3004 Victoria, Australia; Departments of Medicine and Immunology, Central and Eastern Clinical School, Alfred Hospital, Monash University, Melbourne, 3004 Victoria, Australia., Ballinger ML; Diabetes and Cell Biology Laboratory, BakerIDI Heart and Diabetes Institute, Melbourne, 3004 Victoria, Australia., Yang SNY; Diabetes and Cell Biology Laboratory, BakerIDI Heart and Diabetes Institute, Melbourne, 3004 Victoria, Australia., Getachew R; Diabetes and Cell Biology Laboratory, BakerIDI Heart and Diabetes Institute, Melbourne, 3004 Victoria, Australia., Itman C; Departments of Biochemistry & Molecular Biology and Anatomy & Developmental Biology, Monash University, Clayton, Victoria 3800, Australia., Loveland K; Departments of Biochemistry & Molecular Biology and Anatomy & Developmental Biology, Monash University, Clayton, Victoria 3800, Australia., Osman N; Diabetes and Cell Biology Laboratory, BakerIDI Heart and Diabetes Institute, Melbourne, 3004 Victoria, Australia; Departments of Medicine and Immunology, Central and Eastern Clinical School, Alfred Hospital, Monash University, Melbourne, 3004 Victoria, Australia., Little PJ; Diabetes and Cell Biology Laboratory, BakerIDI Heart and Diabetes Institute, Melbourne, 3004 Victoria, Australia; Departments of Medicine and Immunology, Central and Eastern Clinical School, Alfred Hospital, Monash University, Melbourne, 3004 Victoria, Australia. Electronic address: peter.little@bakeridi.edu.au.

Publikováno v: The Journal of biological chemistry [J Biol Chem] 2010 Aug 27; Vol. 285 (35), pp. 26798-26805. Date of Electronic Publication: 2010 Jun 22.